Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessgonadal mesoderm development

TSPY4 TSPY9

4.65e-059242GO:0007506
GeneOntologyBiologicalProcessventricular trabecula myocardium morphogenesis

UBE4B ENG

1.75e-0417242GO:0003222
GeneOntologyCellularComponentexternal side of plasma membrane

SIGLEC12 ENG MUC16 CNTFR CUBN

2.66e-04519245GO:0009897
HumanPhenoRight-to-left shunt

ENG TLL1

9.70e-06472HP:0001694
DomainBMP_1/tolloid-like

TLL1 TLL2

3.97e-063222IPR015446
DomainPeptidase_M12A

TLL1 TLL2

1.98e-056222IPR001506
DomainAstacin

TLL1 TLL2

1.98e-056222PF01400
DomainCUB

TLL1 TLL2 CUBN

2.52e-0549223PF00431
DomainCUB

TLL1 TLL2 CUBN

2.68e-0550223SM00042
Domain-

TLL1 TLL2 CUBN

3.02e-05522232.60.120.290
DomainCUB

TLL1 TLL2 CUBN

3.20e-0553223PS01180
DomainCUB_dom

TLL1 TLL2 CUBN

3.98e-0557223IPR000859
DomainEGF_CA

TLL1 TLL2 CUBN

1.36e-0486223PF07645
DomainEGF_Ca-bd_CS

TLL1 TLL2 CUBN

1.95e-0497223IPR018097
DomainEGF_CA

TLL1 TLL2 CUBN

2.07e-0499223PS01187
DomainEGF-type_Asp/Asn_hydroxyl_site

TLL1 TLL2 CUBN

2.53e-04106223IPR000152
DomainEGF_CA

TLL1 TLL2 CUBN

3.82e-04122223SM00179
DomainEGF-like_Ca-bd_dom

TLL1 TLL2 CUBN

4.01e-04124223IPR001881
DomainEGF

TLL1 TLL2 CUBN

4.20e-04126223PF00008
DomainZnMc

TLL1 TLL2

5.27e-0429222SM00235
DomainPeptidase_Metallo

TLL1 TLL2

5.27e-0429222IPR006026
DomainImmunoglobulin

SIGLEC12 CNTFR IGSF1

1.38e-03190223IPR013151
Domainig

SIGLEC12 CNTFR IGSF1

1.38e-03190223PF00047
DomainIg_sub2

SIGLEC12 CNTFR IGSF1

2.54e-03235223IPR003598
DomainEGF

TLL1 TLL2 CUBN

2.54e-03235223SM00181
DomainEGF_3

TLL1 TLL2 CUBN

2.54e-03235223PS50026
DomainIGc2

SIGLEC12 CNTFR IGSF1

2.54e-03235223SM00408
DomainEGF-like_dom

TLL1 TLL2 CUBN

2.99e-03249223IPR000742
DomainEGF_1

TLL1 TLL2 CUBN

3.20e-03255223PS00022
DomainEGF-like_CS

TLL1 TLL2 CUBN

3.41e-03261223IPR013032
DomainEGF_2

TLL1 TLL2 CUBN

3.56e-03265223PS01186
Domain-

TLL1 TLL2

4.06e-03812223.40.390.10
DomainMetalloPept_cat_dom

TLL1 TLL2

4.06e-0381222IPR024079
DomainZINC_PROTEASE

TLL1 TLL2

5.88e-0398222PS00142
DomainIg_sub

SIGLEC12 CNTFR IGSF1

1.27e-02421223IPR003599
DomainIG

SIGLEC12 CNTFR IGSF1

1.27e-02421223SM00409
DomainIG_LIKE

SIGLEC12 CNTFR IGSF1

1.92e-02491223PS50835
DomainIg-like_dom

SIGLEC12 CNTFR IGSF1

2.04e-02503223IPR007110
PathwayREACTOME_ANCHORING_FIBRIL_FORMATION

TLL1 TLL2

1.42e-0415172M27161
PathwayREACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS

TLL1 TLL2

2.07e-0418172M27164
PathwayREACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS

TLL1 TLL2

2.07e-0418172MM14882
Pubmed

Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures.

TLL1 TLL2

4.56e-07224211313359
Pubmed

Structural basis for the substrate specificity of bone morphogenetic protein 1/tolloid-like metalloproteases.

TLL1 TLL2

1.37e-06324218824173
Pubmed

Assignment of TLL1 and TLL2, which encode human BMP-1/Tolloid-related metalloproteases, to chromosomes 4q32-->q33 and 10q23-->q24 and assignment of murine Tll2 to chromosome 19.

TLL1 TLL2

1.37e-06324210516436
Pubmed

Mammalian tolloid proteinases: role in growth factor signalling.

TLL1 TLL2

2.74e-06424227391803
Pubmed

Mammalian BMP-1/Tolloid-related metalloproteinases, including novel family member mammalian Tolloid-like 2, have differential enzymatic activities and distributions of expression relevant to patterning and skeletogenesis.

TLL1 TLL2

4.56e-06524210479448
Pubmed

Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter.

ENG CNTFR

4.13e-05142422034277
Pubmed

A mouse knockout library for secreted and transmembrane proteins.

SIGLEC12 MUC16 TNFRSF25 FAM3B

2.60e-0446024420562862
Pubmed

Comparative mapping of 50 human chromosome 9 loci in the laboratory mouse.

ENG CNTFR

6.16e-04532427774911
CytobandYp11.2

TSPY4 TSPY9

1.11e-0394242Yp11.2
CytobandEnsembl 112 genes in cytogenetic band chrYp11

TSPY4 TSPY9

2.79e-03150242chrYp11
CytobandEnsembl 112 genes in cytogenetic band chr7q21

CDK14 DYNC1I1

3.90e-03178242chr7q21
GeneFamilyBone morphogenetic proteins|Astacins

TLL1 TLL2

8.34e-066142894
GeneFamilyImmunoglobulin like domain containing

CNTFR IGSF1

9.48e-03193142594
CoexpressionGSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP

PIP5K1C BCAT1 CNTFR CUBN

2.00e-05187234M6809
ToppCellE17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ENG TSHZ2 DYNC1I1 TLL1

2.37e-061782440139b42494c1186390b12106dea7957e2b6717c2
ToppCelldroplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSHZ2 DYNC1I1 GRIK4 CUBN

2.64e-0618324419e7be1cfdd111bfb840532a6f7c780345dffccf
ToppCelldroplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSHZ2 DYNC1I1 GRIK4 CUBN

2.64e-06183244b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0
ToppCellP03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ENG TSHZ2 DYNC1I1 TLL1

2.94e-061882445eb107122064f0a99dfd445cc87d3766f7257216
ToppCellP28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TSHZ2 DYNC1I1 GRIK4 CNTFR

3.33e-061942443c661c6768c3f05d2aba03d329adb257ca201b2d
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CDK14 TSHZ2 DYNC1I1 GRIK4

3.33e-06194244011e14d9ed1393275f892060e7708ffadcd0767f
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

CDK14 TSHZ2 DYNC1I1 GRIK4

3.47e-061962441450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell5'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ENG TSHZ2 DYNC1I1 TLL1

3.61e-06198244d7e15e61b6018e4c36461c9471ee29601929925c
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CDK14 TSHZ2 DYNC1I1 GRIK4

3.61e-0619824417dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCellfacs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABHD3 FAM3B CUBN

9.26e-051652434f95c2fe5ab4416c736fe0d1936695a2b26777eb
ToppCelldroplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABHD3 CDK14 CUBN

9.26e-0516524321a82a975f550080b6674750b06212205cd16742
ToppCellfacs-Marrow-KLS-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABHD3 FAM3B CUBN

9.26e-051652433e913b49a868fdd5589200ae3e9be77c0938ba14
ToppCellTCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-4|TCGA-Liver / Sample_Type by Project: Shred V9

ABHD3 GRIK4 IGSF1

9.94e-051692430a3ba6b5d6cff9d3d7f56046063cfc3a37ae1156
ToppCellE17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

BCAT1 CDRT4 DYNC1I1

9.94e-0516924358e22f9119240664515fe91ca53812611a8f17d6
ToppCellEndothelial-B-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

TSHZ2 DYNC1I1 TLL1

9.94e-051692438889c9e8af1ab0b093d57b69abd80b59b3461be9
ToppCellE17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TSHZ2 DYNC1I1 TLL1

1.01e-041702437fa022471e14ac8a3bc147c793368a4d56a8e591
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L5_RORB_LINC01202|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TSHZ2 TLL1 IGSF1

1.01e-0417024387cac555f16b6c2ef3d1b3a00f992d8bf2237b50
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ENG TSHZ2 TLL1

1.05e-04172243fc092a0631555d79e00ef9890cbd806e15bca2d4
ToppCellPND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ENG TSHZ2 TLL1

1.05e-04172243745725bd10c82017d678463b8fef0d2dcf09a8fd
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D122|Adult / Lineage, Cell type, age group and donor

TSHZ2 DYNC1I1 TLL1

1.07e-04173243dba09ba9748871e38a16449d500ae4d7b405c42f
ToppCellEndothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

TSHZ2 DYNC1I1 TLL1

1.07e-04173243a81992965137195d20fc498f750975303961a828
ToppCellMild-CD4+_T_Exhausted|Mild / Disease group and Cell class

CDK14 TSHZ2 TNFRSF25

1.10e-041752436df099f37875f2cd63502b732a2e07ebfec50e47
ToppCell3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

PIK3R5 TNFRSF25 GRIK4

1.10e-04175243f2c3e0f728a43d6988e793c8a50c964f7447db82
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 DYNC1I1 CNTFR

1.10e-04175243795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCellControl-Neuronal_cells|Control / group, cell type (main and fine annotations)

TSHZ2 DYNC1I1 TLL1

1.12e-04176243c29d09ecf0eb17f767d78af4b7f2e7725c967ff8
ToppCellControl-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations)

TSHZ2 DYNC1I1 TLL1

1.12e-0417624398c07d26ba0dc0fe15ca0ea81f633d4591782bd1
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor

TSHZ2 DYNC1I1 TLL1

1.16e-04178243c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCellT_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

CDK14 TSHZ2 BCAT1

1.16e-04178243e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCelldroplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSHZ2 DYNC1I1 CNTFR

1.20e-04180243423454e3390080ae03bb3cbb267255ebfe4df080
ToppCelldroplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TSHZ2 DYNC1I1 CNTFR

1.20e-04180243dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ENG BCAT1 TLL1

1.24e-041822433cbeaf7904a76c32137a00abb20e302d3d3c8bb8
ToppCell3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ENG BCAT1 TLL1

1.24e-04182243d996ceb77c83591df4cef144ca72862f31d9777f
ToppCell5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ENG TSHZ2 TLL1

1.26e-04183243a644258ba90acc62d571623e429d72ffc4b69203
ToppCellEndothelial-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id

ENG TSHZ2 TLL1

1.26e-041832432c3f2c25c38f0598b4787d2ec335efe00fdc9751
ToppCell5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TSHZ2 DYNC1I1 TLL1

1.26e-041832432d0d3b486498a7903fa9a1f48b189291da49c430
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SIGLEC12 ENG BCAT1

1.28e-04184243e343dd7777a29048e3f12a939f7f782b8b7b4fea
ToppCellCOVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations)

TSHZ2 DYNC1I1 TLL1

1.30e-0418524336ce23893915f5c380cca39b2c33a516edf31c3a
ToppCellCOVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations)

TSHZ2 DYNC1I1 TLL1

1.30e-041852434a095829992b39856a73bdfac03ee68b9aa0d3b8
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ABHD3 CNTFR IGSF1

1.32e-04186243ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b
ToppCellAdult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor

CDK14 TLL1 CUBN

1.34e-04187243ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCellPND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ENG DYNC1I1 TLL1

1.34e-0418724363834420db930df91b62494c9d7aaa9a25bca530
ToppCellPND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ENG DYNC1I1 TLL1

1.34e-041872436cf7be5401b81a4eeb30840fb3733d61a24af539
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 TSHZ2 FAM3B

1.34e-04187243f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor

TSHZ2 DYNC1I1 TLL1

1.36e-04188243c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

TSHZ2 DYNC1I1 TLL1

1.36e-04188243aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCelldroplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DYNC1I1 GRIK4 CUBN

1.38e-04189243cd42ce4aa217d0bd95e0cc0ba357bdfeb3e55a48
ToppCelldroplet-Lung-21m-Mesenchymal-myofibroblast-myofibroblast_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DYNC1I1 GRIK4 CUBN

1.38e-04189243102501eee7760d5882dec41ea9d00147b3f4fb73
ToppCellCOVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type

TSHZ2 DYNC1I1 TLL1

1.38e-04189243c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

BCAT1 PIK3R5 GRIK4

1.38e-041892437ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCelldroplet-Lung-21m-Mesenchymal-myofibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DYNC1I1 GRIK4 CUBN

1.38e-041892436e83bf855d4771885b60bb8992df2f9b508eef97
ToppCellAdult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor

TSHZ2 DYNC1I1 TLL1

1.41e-0419024391bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCellfacs-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DYNC1I1 GRIK4 CNTFR

1.41e-04190243c7bd087f36321cec61b98657433b4d19d135791f
ToppCellfacs-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DYNC1I1 GRIK4 CNTFR

1.41e-04190243834218fcc59df5e7e52de154272f3d55d81d0dac
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TSHZ2 DYNC1I1 TLL1

1.41e-041902436e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 DYNC1I1 CNTFR

1.41e-04190243efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TSHZ2 DYNC1I1 TLL1

1.41e-041902436b704deeb44e1ffa10e604d0e5612b022f6cd9a6
ToppCellPCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 DYNC1I1 GRIK4

1.43e-04191243fa380a8752de158974b2ae5e741573439719cc0d
ToppCell18-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class

ENG CNTFR IGSF1

1.43e-0419124386ce98d2c90c196474b06869de888cf5d1eed196
ToppCelldroplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ENG TSHZ2 TLL1

1.43e-04191243c379a499dabf3c9ed80f47adbb2d949821c5b053
ToppCelldroplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ENG TSHZ2 TLL1

1.43e-041912439fc674a58f20b47255e4457d5195c8cff17b0414
ToppCelldroplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ENG TSHZ2 TLL1

1.45e-041922431990dc8a81594018a5bf596be99d0b5f0af0f58f
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

CDK14 ENG TSHZ2

1.45e-0419224360b1312e84f6d6448365a952469c506c00b5fe93
ToppCelldroplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ENG TSHZ2 TLL1

1.45e-04192243845cc9c18b4436b07dd3ce7980052683937546d2
ToppCelldroplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ENG TSHZ2 TLL1

1.45e-04192243c72a082c93a8825adbfef37f889ba3a7052f201b
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 BCAT1 IGSF1

1.45e-041922434c9d748f209cc1e13d28c8c7f5180ab8522e0fbf
ToppCellCOPD-Endothelial-Lymphatic|World / Disease state, Lineage and Cell class

TSHZ2 DYNC1I1 TLL1

1.47e-0419324325bdc557055b5bce6a21f8696b48e991c696b979
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DYNC1I1 CNTFR CUBN

1.47e-041932432b80991e7ba7640f7ab2139d30e4c54d8e533862
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ENG TSHZ2 CNTFR

1.47e-04193243826b8dd801298b3e0cd76232feae5a14026b8806
ToppCelldroplet-Lung-1m-Mesenchymal-myofibroblast-myofibroblast_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DYNC1I1 CNTFR CUBN

1.47e-0419324390cfc34c2d0d7c70f071703d35db1d6037961481
ToppCell5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ENG TSHZ2 TLL1

1.47e-04193243c0973a2c97deb7176c2f617c8760a55f7edc9839
ToppCellP15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ENG TSHZ2 TLL1

1.47e-041932435f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ENG TSHZ2 CNTFR

1.47e-0419324387d3a577d37fb0cb4b6313c596310de452bc3872
ToppCelldroplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ENG TSHZ2 CNTFR

1.47e-04193243d485634c564b268e344b6a2863c26f6adaec9e38
ToppCellnucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TSHZ2 DYNC1I1 TLL1

1.49e-04194243f772a9f9ef8635aeaeb8b022dbb94e9672b36ead
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 DYNC1I1 GRIK4

1.49e-04194243b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 DYNC1I1 CNTFR

1.49e-04194243c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCellP15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

TSHZ2 GRIK4 CNTFR

1.49e-041942435f04d21c4e2d36e74b6c5889aa97fd98f75a0973
ToppCellnucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TSHZ2 DYNC1I1 TLL1

1.49e-041942435d2b3ed5374e2ab10c1c7eb3a03139fc95036a48
ToppCellnucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TSHZ2 DYNC1I1 TLL1

1.49e-041942433b73f2d305a7566f7ab567e5f18c82cd3d80e32c
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SIGLEC12 ENG BCAT1

1.49e-0419424312e42433a7b7c17c46049ef450223daf2976a59a
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DYNC1I1 GRIK4 CNTFR

1.52e-04195243c6bb16c0076639c6ddef1a15d8cba44bc29c077d
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 BCAT1 GRIK4

1.52e-04195243c5d2d9f12fd893331c9de261af30607d845d4f6a
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 DYNC1I1 CNTFR

1.52e-041952433c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCelldroplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DYNC1I1 CNTFR CUBN

1.52e-04195243d32716a12014522492becbde1088dc1106308490
ToppCell5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TSHZ2 DYNC1I1 TLL1

1.52e-04195243590c0dc0db4dc62879645ed7f61292ff97d2c7d5
ToppCelldroplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DYNC1I1 CNTFR CUBN

1.52e-04195243b913d5df50c88a3a255f516a1aa42419c6701e1e
ToppCellfacs-Lung-3m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

DYNC1I1 GRIK4 CNTFR

1.52e-04195243ea89f80d3d7e9f737442f7c1aa1791d277ffc90c
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 DYNC1I1 GRIK4

1.52e-041952430e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCellPCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

CDK14 TSHZ2 CNTFR

1.54e-04196243dca52c57ba35d9395cdbca8b881f12ece721b10f
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 DYNC1I1 GRIK4

1.56e-0419724331a1852911bda38543916585fda34255fd62a134
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 TSHZ2 FAM3B

1.56e-04197243ec08a971e8dd9ad69359896c60ad77ff8af08fd0
ToppCellMonocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

ENG BCAT1 PIK3R5

1.56e-041972438a058c9d9285acd7cf2fb8e34f7602a86b5d6c89
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 DYNC1I1 GRIK4

1.56e-041972430034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCellPCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

CDK14 TSHZ2 DYNC1I1

1.56e-0419724373a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCellT_cells-Treg_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis

CDK14 TSHZ2 TNFRSF25

1.56e-04197243ec9398ae3577f61d6b1e6aba50ef4261aaaa7610
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

TSHZ2 DYNC1I1 GRIK4

1.56e-0419724311a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 TSHZ2 FAM3B

1.59e-041982439718f4c013c347f1b3c785ae232dd2fb6c1fe298
ToppCellmoderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

MUC16 TSHZ2 FAM3B

1.59e-041982437d96d7105a849c7280ce87bd76ce130ac47384fd
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MUC16 TSHZ2 FAM3B

1.59e-041982433cc9e671f596ef0829684018e4257571fefb6267
ToppCellcellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

MUC16 TSHZ2 FAM3B

1.59e-041982436e047de63ef59dcb47e4fc06b173b2a02fdcf4c9
Drugnifedipine; Up 200; 10uM; MCF7; HG-U133A

ABHD3 TNFRSF25 DYNC1I1 CNTFR LMF2

1.13e-06199225603_UP
DrugMethotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A

CDK14 BCAT1 TNFRSF25 LMF2

2.99e-051892242041_DN
DrugSuccinylsulfathiazole [116-43-8]; Down 200; 11.2uM; HL60; HT_HG-U133A

CDK14 UBE4B BCAT1 PIK3R5

3.25e-051932242166_DN
DrugFuraltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A

PIK3R5 TNFRSF25 DYNC1I1 CNTFR

3.31e-051942243838_UP
Drug2-propylpentanoic acid; Up 200; 2000uM; MCF7; HG-U133A

PIP5K1C UBE4B TNFRSF25 CUBN

3.31e-05194224346_UP
Drugsodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A

ABHD3 UBE4B ENG CNTFR

3.52e-05197224407_UP
Drug1-phenylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A

UBE4B CNTFR IGSF1 CUBN

3.52e-0519722422_DN
DrugCotinine (-) [486-56-6]; Up 200; 22.6uM; MCF7; HT_HG-U133A

CDK14 PIK3R5 TNFRSF25 LMF2

3.52e-051972245611_UP
DrugICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A

CDK14 PIP5K1C UBE4B TNFRSF25

3.59e-051982241238_DN
DrugFurosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A

PIK3R5 TNFRSF25 DYNC1I1 LMF2

3.59e-051982243197_UP
DrugCytisine (-) [485-35-8]; Down 200; 21uM; HL60; HG-U133A

ABHD3 CDK14 ENG BCAT1

3.59e-051982241766_DN
DrugcarAa

FAM3B GRIK4

5.85e-0512222CID000166765
Drugtriadimenol

TLL1 TLL2

2.64e-0425222CID000041368
DrugAC1L2T2K

FAM3B GRIK4

2.86e-0426222CID000128038
Drugethyldichloroarsine

ENG FAM3B

5.20e-0435222CID000011711
Drugquinolinic acid

DYNC1I1 GRIK4 CNTFR

6.59e-04179223CID000001066
Drug2-propylpentanoic acid; Up 200; 10000uM; MCF7; HG-U133A

ABHD3 PIP5K1C UBE4B

7.48e-04187223345_UP
DrugTamoxifen citrate [54965-24-1]; Up 200; 7uM; MCF7; HT_HG-U133A

CDK14 PIK3R5 TNFRSF25

7.48e-041872236768_UP
DrugHycanthone [3105-97-3]; Down 200; 11.2uM; HL60; HG-U133A

CDK14 BCAT1 PIK3R5

7.48e-041872231614_DN
DrugEthacrynic acid [58-54-8]; Up 200; 13.2uM; HL60; HG-U133A

ABHD3 UBE4B LMF2

7.48e-041872231565_UP
Drug17-AAG; Down 200; 1uM; PC3; HT_HG-U133A

CDK14 PIP5K1C TNFRSF25

7.72e-041892231206_DN
DrugDicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A

CDK14 TNFRSF25 CNTFR

7.84e-041902233848_UP
Drugtrichostatin A; Up 200; 0.1uM; MCF7; HG-U133A

ABHD3 UBE4B ENG

7.84e-04190223331_UP
DrugAlexidine dihydrochloride [22573-93-9]; Down 200; 6.8uM; PC3; HT_HG-U133A

PIP5K1C UBE4B DYNC1I1

7.96e-041912237397_DN
DrugImipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

PIP5K1C UBE4B IGSF1

7.96e-041912235997_DN
DrugPimozide [2062-78-4]; Up 200; 8.6uM; HL60; HG-U133A

ENG TNFRSF25 CNTFR

8.08e-041922231562_UP
DrugAmethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A

ABHD3 ENG TNFRSF25

8.08e-041922231599_DN
DrugGallamine triethiodide [65-29-2]; Down 200; 4.4uM; HL60; HG-U133A

ABHD3 PIK3R5 LMF2

8.20e-041932231375_DN
Drugradicicol; Up 200; 0.1uM; HL60; HG-U133A

ABHD3 UBE4B CNTFR

8.20e-04193223544_UP
DrugPrazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A

CDK14 UBE4B BCAT1

8.20e-041932233098_DN
DrugLithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A

TNFRSF25 TLL2 LMF2

8.32e-041942234373_UP
DrugGlimepiride [93479-97-1]; Up 200; 8.2uM; PC3; HT_HG-U133A

TNFRSF25 CNTFR CUBN

8.32e-041942236628_UP
DrugPiroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A

ABHD3 ENG BCAT1

8.32e-041942231405_DN
DrugJosamycin [16846-24-5]; Up 200; 4.8uM; HL60; HG-U133A

ENG BCAT1 IGSF1

8.32e-041942232034_UP
Drug2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A

CDK14 PIK3R5 TNFRSF25

8.45e-041952235574_UP
DrugIodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A

BCAT1 PIK3R5 TNFRSF25

8.45e-041952234848_UP
DrugCarbarsone [121-59-5]; Up 200; 15.4uM; PC3; HT_HG-U133A

BCAT1 TNFRSF25 CUBN

8.45e-041952233991_UP
DrugPentoxifylline [6493-05-6]; Up 200; 14.4uM; MCF7; HT_HG-U133A

PIK3R5 TNFRSF25 LMF2

8.45e-041952232290_UP
DrugMethoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; HL60; HT_HG-U133A

UBE4B BCAT1 LMF2

8.58e-041962232488_DN
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA

ABHD3 PIP5K1C IGSF1

8.58e-041962231041_UP
DrugEthosuximide [77-67-8]; Up 200; 28.4uM; MCF7; HT_HG-U133A

CDK14 BCAT1 TNFRSF25

8.58e-041962232280_UP
DrugPyrimethamine [58-14-0]; Up 200; 16uM; PC3; HG-U133A

ENG TNFRSF25 CNTFR

8.58e-041962231894_UP
DrugSulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A

PIK3R5 TNFRSF25 CNTFR

8.58e-041962233847_UP
Drug0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A

PIP5K1C UBE4B TNFRSF25

8.58e-041962237391_DN
DrugLomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A

TNFRSF25 CNTFR LMF2

8.58e-041962232310_UP
DrugOrphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A

TNFRSF25 CNTFR LMF2

8.58e-041962234359_DN
DrugEtodolac [41340-25-4]; Up 200; 14uM; MCF7; HT_HG-U133A

UBE4B TNFRSF25 TLL1

8.58e-041962232254_UP
DrugMethazolamide [554-57-4]; Down 200; 17uM; HL60; HT_HG-U133A

CDK14 UBE4B PIK3R5

8.58e-041962232733_DN
DrugAC1L97HB

FAM3B CNTFR

8.60e-0445222CID000439504
DrugBicuculline (+) [485-49-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A

CDK14 BCAT1 TNFRSF25

8.70e-041972234397_UP
DrugGSK-3 Inhibitor IX; Up 200; 0.5uM; PC3; HT_HG-U133A

UBE4B TNFRSF25 LMF2

8.70e-041972236585_UP
Drugretinoic acid; Down 200; 1uM; MCF7; HG-U133A

ENG DYNC1I1 LMF2

8.70e-04197223224_DN
DrugIsoconazole [27523-40-6]; Down 200; 9.6uM; MCF7; HT_HG-U133A

PIP5K1C TNFRSF25 LMF2

8.70e-041972232218_DN
DrugKetotifen fumarate [34580-14-8]; Up 200; 9.4uM; HL60; HG-U133A

ABHD3 PIK3R5 CNTFR

8.70e-041972231583_UP
DrugSotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A

TNFRSF25 LMF2 IGSF1

8.70e-041972234160_DN
DrugAlfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A

PIK3R5 TNFRSF25 TLL2

8.70e-041972235242_UP
DrugGliclazide [21187-98-4]; Up 200; 12.4uM; PC3; HT_HG-U133A

ENG TNFRSF25 TLL2

8.70e-041972235089_UP
Drugclofibrate; Down 200; 150uM; MCF7; HG-U133A

ENG TNFRSF25 LMF2

8.70e-04197223263_DN
Drugrofecoxib; Down 200; 10uM; HL60; HG-U133A

ABHD3 BCAT1 LMF2

8.70e-04197223371_DN
Drug2-propylpentanoic acid; Down 200; 50uM; PC3; HT_HG-U133A

TNFRSF25 DYNC1I1 LMF2

8.70e-041972231222_DN
DrugProguanil hydrochloride [637-32-1]; Up 200; 13.8uM; HL60; HT_HG-U133A

ABHD3 ENG PIK3R5

8.70e-041972232944_UP
Drugnovobiocin sodium, USP; Up 200; 100uM; MCF7; HG-U133A

CDK14 ENG CUBN

8.70e-04197223576_UP
DrugCephalothin sodium salt [58-71-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A

PIP5K1C LMF2 IGSF1

8.70e-041972236819_DN
DrugStachydrine hydrochloride; Up 200; 22.2uM; MCF7; HT_HG-U133A

CDK14 BCAT1 TLL2

8.70e-041972236805_UP
DrugThioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; HL60; HG-U133A

PIK3R5 TNFRSF25 LMF2

8.70e-041972231986_DN
Drugthioridazine hydrochloride; Up 200; 1uM; MCF7; HG-U133A

UBE4B TNFRSF25 DYNC1I1

8.70e-04197223422_UP
DrugPantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; MCF7; HT_HG-U133A

TNFRSF25 CNTFR LMF2

8.83e-041982233248_UP
Drug(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; PC3; HT_HG-U133A

UBE4B TNFRSF25 LMF2

8.83e-041982236343_DN
DrugIproniazide phosphate [305-33-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A

TNFRSF25 TLL1 CNTFR

8.83e-041982232288_UP
DrugAdrenosterone [382-45-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A

PIK3R5 LMF2 IGSF1

8.83e-041982235464_UP
DrugBenfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A

TNFRSF25 DYNC1I1 GRIK4

8.83e-041982233931_UP
DrugPiracetam [7491-74-9]; Up 200; 28.2uM; HL60; HG-U133A

ABHD3 UBE4B CNTFR

8.83e-041982231710_UP
DrugIsoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A

UBE4B TNFRSF25 LMF2

8.83e-041982232246_DN
DrugPentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A

ENG TNFRSF25 LMF2

8.83e-041982237375_UP
Drugindomethacin, USP; Down 200; 100uM; MCF7; HG-U133A

UBE4B DYNC1I1 LMF2

8.83e-04198223453_DN
DrugMifepristone [84371-65-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A

TSHZ2 PIK3R5 TNFRSF25

8.83e-041982233185_UP
DrugNitrarine dihydrochloride [20069-05-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A

PIP5K1C TNFRSF25 LMF2

8.83e-041982236043_DN
DrugChlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A

PIP5K1C TNFRSF25 LMF2

8.83e-041982232217_DN
DrugNicardipine hydrochloride [54527-84-3]; Down 200; 7.8uM; PC3; HT_HG-U133A

UBE4B DYNC1I1 LMF2

8.83e-041982236297_DN
DrugMilrinone [78415-72-2]; Up 200; 19uM; PC3; HT_HG-U133A

TNFRSF25 CNTFR LMF2

8.83e-041982235856_UP
DrugEpivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A

ABHD3 PIP5K1C LMF2

8.83e-041982236838_DN
DrugMilrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A

PIP5K1C UBE4B LMF2

8.83e-041982237210_DN
DrugUrosiol [128-13-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A

CDK14 BCAT1 TNFRSF25

8.83e-041982236484_UP
DrugPrazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A

BCAT1 TNFRSF25 CNTFR

8.83e-041982235416_UP
DrugTiclopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; PC3; HG-U133A

TSHZ2 PIK3R5 CNTFR

8.83e-041982231895_UP
DrugTranexamic acid [1197-18-8]; Down 200; 25.4uM; PC3; HT_HG-U133A

UBE4B TNFRSF25 DYNC1I1

8.83e-041982232085_DN
DrugStreptomycin sulfate [3810-74-0]; Down 200; 2.8uM; PC3; HT_HG-U133A

UBE4B TNFRSF25 DYNC1I1

8.83e-041982235837_DN
DrugTiclopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; PC3; HT_HG-U133A

CDK14 TNFRSF25 DYNC1I1

8.83e-041982234074_DN
DrugBetamethasone [378-44-9]; Down 200; 10.2uM; HL60; HG-U133A

CDK14 PIP5K1C LMF2

8.83e-041982231590_DN
DrugMolsidomine [25717-80-0]; Up 200; 16.6uM; PC3; HT_HG-U133A

UBE4B ENG TNFRSF25

8.96e-041992236325_UP
Drug1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A

UBE4B IGSF1 CUBN

8.96e-0419922361_DN
DrugMebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A

CDK14 TNFRSF25 LMF2

8.96e-041992236795_UP
DrugLevamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; MCF7; HT_HG-U133A

PIP5K1C PIK3R5 CNTFR

8.96e-041992237450_UP
Drug(-)-quinpirole hydrochloride; Down 200; 1uM; MCF7; HG-U133A

ENG DYNC1I1 LMF2

8.96e-04199223456_DN
DrugMetolazone [17560-51-9]; Up 200; 11uM; PC3; HG-U133A

PIP5K1C TNFRSF25 LMF2

8.96e-041992231932_UP
DrugGlimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A

PIK3R5 TNFRSF25 CNTFR

8.96e-041992234973_UP
DrugNomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A

PIP5K1C TNFRSF25 LMF2

8.96e-041992232224_DN
DrugTetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; HL60; HG-U133A

UBE4B ENG CUBN

8.96e-041992231739_UP
Drugtetraethylenepentamine pentahydrochloride; Down 200; 100uM; ssMCF7; HG-U133A

TSHZ2 TNFRSF25 LMF2

8.96e-04199223498_DN
DrugMetoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

BCAT1 TNFRSF25 LMF2

8.96e-041992233625_UP
Diseaselateral ventricle volume measurement

CDRT4 GRIK4

2.76e-0433222EFO_0008487
Diseaseprimary dental caries

TLL1 CUBN

2.93e-0434222EFO_0600095
Diseasepentachlorophenol measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022071
Diseaseparathion measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022070
Diseasepotassium chromate measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022072
Diseasemercuric chloride measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022068
Diseaseheptachlor epoxide measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022067
Diseasemethoxychlor measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022069
Disease4,6-dinitro-o-cresol measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022053
Disease2,4,5-trichlorophenol measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022052
Diseaseazinphos methyl measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022055
Diseasealdrin measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022054
Diseasedicofol measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022060
Diseasedisulfoton measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022062
Diseasedieldrin measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022061
Diseaseendrin measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022064
Diseaseendosulfan measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022063
Diseaseheptachlor measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022066
Diseaseethion measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022065
Diseasechlorpyrifos measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022057
Diseasecadmium chloride measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022056
Diseasediazinon measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022059
Diseasedibutyl phthalate measurement

MUC16 TSHZ2

1.35e-0373222EFO_0022058
Diseaseenvironmental exposure measurement

MUC16 TSHZ2

1.35e-0373222EFO_0008360
DiseaseDDT metabolite measurement

MUC16 TSHZ2

1.39e-0374222EFO_0007886
Diseaseattention deficit hyperactivity disorder

TSHZ2 GRIK4 TLL2

2.23e-03354223EFO_0003888
Diseasecoronary artery disease (is_implicated_in)

TLL1 CUBN

2.51e-03100222DOID:3393 (is_implicated_in)
Diseaseblood cobalt measurement

MUC16 TSHZ2

2.56e-03101222EFO_0007577
Diseaseblood nickel measurement

MUC16 TSHZ2

3.59e-03120222EFO_0007583

Protein segments in the cluster

PeptideGeneStartEntry
WVPYSTSASLYIRPT

BCAT1

151

P54687
DHCPVVTETYYPTVW

ABHD3

71

Q8WU67
HTYSNEVVTLWYRPP

CDK14

286

O94921
WYIYSHTRSPSKREP

ENG

611

P17813
HDPWPAYVTYTSQTV

CDRT4

26

Q8N9R6
YNRRYWTPATSTPVT

MUC16

12036

Q8WXI7
FYTIHCTGYLRSWPP

ARNTL2

311

Q8WYA1
LTWDTCYFHYLVPTP

DYNC1I1

81

O14576
WTPCPSDTYAYRLLS

FAM3B

66

P58499
YPSPYRSNTDCSWVI

CUBN

1526

O60494
TYSCSYRVETHPNIW

IGSF1

481

Q8N6C5
YCSWHLPTPTYIPNT

CNTFR

126

P26992
ARLTPYEWYSPHPCA

GRIK4

566

Q16099
HPEPYERYVTTVTSW

C5orf34

521

Q96MH7
PNGYPSYTHCIWRVS

TLL1

366

O43897
TYHYETQCLPTPAAW

LMF2

201

Q9BU23
PTDERSWVYSPLHYS

PIP5K1C

641

O60331
CVSVPCSVLYPHYNW

SIGLEC12

166

Q96PQ1
CSVLYPHYNWTASSP

SIGLEC12

171

Q96PQ1
TEYRASHSTPIEWYP

TSPY9

231

A0A494C1R9
TEYRASHSTPIEWYP

TSPY4

231

P0CV99
ASTYHRFLTWPVPYC

PIK3R5

106

Q8WYR1
SSPRYRPYTVTHPWA

UBE4B

326

O95155
YPSYSHCVWRISVTP

TLL2

371

Q9Y6L7
TYTYRHCWPHKPLVT

TNFRSF25

221

Q93038
PSWSAYPSIHAAYQL

TSHZ2

536

Q9NRE2